• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ALTRUA 60; IMPLANTABLE PULSE GENERATOR, PACEMAKER (NON-CRT)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ALTRUA 60; IMPLANTABLE PULSE GENERATOR, PACEMAKER (NON-CRT) Back to Search Results
Model Number S606
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); Use of Device Problem (1670)
Patient Problems No Known Impact Or Consequence To Patient (2692); No Code Available (3191); Insufficient Information (4580)
Event Date 07/24/2020
Event Type  Injury  
Manufacturer Narrative
No additional information is available.If additional information becomes available the report will be updated at that time.
 
Event Description
It was reported that the pacemaker was showing a message it was in magnet mode when there was no magnet present.Boston scientific technical services (ts) was consulted and walked the field representative through attempting to reset the magnet operating from asynchronous to off but it would not allow any programming.Electrogram (egms) were also not available.Ts noted that the pacemaker appears to be not performing as intended and recommended replacement.At this time the pacemaker remains in service and no adverse patient effects were reported.
 
Manufacturer Narrative
Patient code (b)(6) captures the reportable event of surgery.At this time, the product has not been returned.If the product is returned, analysis will be performed and this report would be updated at that time.
 
Event Description
Additional information as received that prior to the explant procedure, the pacemaker was interrogated and showed normal device function with no magnet mode noted.The battery status showed two years remaining.The field representative consulted boston scientific technical services (ts) who noted that since it was confirmed at the last check that the device was stuck in a magnet mode and the issue could not be resolved with troubleshooting, they could not guarantee that this behavior would not happen again in this device.Ts recommended device replacement.Subsequently the pacemaker was explanted and replaced.No additional adverse patient effects were reported.
 
Event Description
It was reported that the pacemaker was showing a message it was in magnet mode when there was no magnet present.Boston scientific technical services (ts) was consulted and walked the field representative through attempting to reset the magnet operating from asynchronous to off but it would not allow any programming.Electrogram (egms) were also not available.Ts noted that the pacemaker appears to be not performing as intended and recommended replacement.At this time the pacemaker remains in service and no adverse patient effects were reported.Additional information as received that prior to the explant procedure, the pacemaker was interrogated and showed normal device function with no magnet mode noted.The battery status showed two years remaining.The field representative consulted boston scientific technical services (ts) who noted that since it was confirmed at the last check that the device was stuck in a magnet mode and the issue could not be resolved with troubleshooting, they could not guarantee that this behavior would not happen again in this device.Ts recommended device replacement.Subsequently the pacemaker was explanted and replaced.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Patient code 3191 captures the reportable event of surgery.At this time, the product has not been returned.If the product is returned, analysis will be performed and this report would be updated at that time.The returned device was thoroughly inspected and analyzed upon receipt at our post market quality assurance laboratory.Visual examination of the device header and case noted no anomalies.The device was then exposed to simulated heart load conditions, and the pacing, and sensing functions were tested.Impedance testing was completed and all measurements were within normal limits.The device operated appropriately with no interruptions in therapy output at the returned programmed settings.A series of electrical tests was also performed, and again, normal device function was observed.Magnet function was tested 15 times.With a magnet applied the pacing rate went to 100 paces per minute with the magnet removed the pacing rate returned to the lower rate limit- normal magnet switch operation was noted during analysis.Analysis did not identify any device characteristics that would have caused or contributed to the reported clinical observations.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALTRUA 60
Type of Device
IMPLANTABLE PULSE GENERATOR, PACEMAKER (NON-CRT)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key10619729
MDR Text Key209600274
Report Number2124215-2020-16753
Device Sequence Number1
Product Code LWP
UDI-Device Identifier00802526484490
UDI-Public00802526484490
Combination Product (y/n)N
PMA/PMN Number
N970003/S106
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup
Report Date 06/25/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date06/28/2012
Device Model NumberS606
Device Catalogue NumberS606
Device Lot Number138895
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/21/2020
Initial Date Manufacturer Received 07/24/2020
Initial Date FDA Received10/02/2020
Supplement Dates Manufacturer Received08/28/2020
04/08/2021
Supplement Dates FDA Received10/19/2020
06/25/2021
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age58 YR
-
-